Individuals with pathogenic variants in the BRCA1 and/or BRCA2 genes face elevated risks of cancer, including a 70% lifetime risk of breast cancer and 40% lifetime risk of ovarian cancer [1]. Here, BRCA2 is linked to breast carcinoma.